EQUITY RESEARCH MEMO

Medsurgpi

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)45/100

MedSurgPI is a privately held medical consulting firm headquartered in San Jose, California, founded in 2010. The company provides specialized consulting services in product development and medical affairs, including fractional chief medical officers, medical monitoring, medical communications, and promotional (LMR) review. Its core focus is supporting medical device and surgical companies navigate regulatory and clinical pathways. Despite a limited public profile, MedSurgPI has established itself as a niche service provider in a growing market. The firm operates without disclosed funding or valuation, which is typical for consulting entities. Given its small scale and service-based model, growth is driven by client acquisition and repeat engagements. The company faces competition from larger consulting firms but differentiates via focused expertise in medical affairs for device development. Near-term outlook depends on maintaining existing relationships and expanding into adjacent therapeutic areas. Without significant public milestones, the company's trajectory remains closely tied to industry demand for outsourced medical affairs support.

Upcoming Catalysts (preview)

  • Q3 2026Major Contract Win with Mid-Tier Device Manufacturer60% success
  • Q1 2027Launch of Expanded Service Line (e.g., Regulatory Strategy)50% success
  • Q4 2026Strategic Partnership with a CRO for Integrated Services40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)